ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Ankylosing spondylitis (AS) and genomics"

  • Abstract Number: 1612 • 2012 ACR/ARHP Annual Meeting

    Ankylosing Spondylitis Is Associated with Single Nucleotide Polymorphisms in Loci Implicating Four Aminopeptidases

    Philip Robinson1, Adrian Cortes1, Paul Leo1, Australian-Anglo-American Spondylitis Consortium (TASC)2, Wellcome Trust Case Control Consortium (WTCCC) .3, International Genetics of Ankylosing Spondylosis Consortium (IGAS)4, David Evans5 and Matthew A. Brown1, 1Human Genetics Group, University of Queensland Diamantina Insititute, Brisbane, Australia, 2University of Queensland Diamantina Institute, Brisbane, Australia, 3Wellcome Trust Case Control Consortium, Wellcome Trust Case Control Consortium, United Kingdom, 4IGAS, Igas, Australia, 5School of Social and Community Medicine, Bristol University, Bristol, United Kingdom

    Background/Purpose: The aim of the study was to examine regions implicated in autoimmune diseases for association with AS. A previous association with AS has been…
  • Abstract Number: 595 • 2012 ACR/ARHP Annual Meeting

    A Genomewide Association Study of Anterior Uveiti

    Dorith Claushuis1, Adrian Cortes2, Linda A. Bradbury1, Tammy M. Martin3, James T. Rosenbaum4, John D. Reveille5, Paul Wordsworth6, Jennifer Pointon6, Australo-Anglo-American Spondyloarthritis Consortium7, David Evans8, Paul Leo2, Pamela Mukhopadhyay2 and Matthew A. Brown2, 1Human Genetics Group, The University of Queensland Diamantina Institute, Brisbane, Australia, 2Human Genetics Group, The University of Queensland Diamantina Insititute, Brisbane, Australia, 3Ophthalmology/L467AD, Oregon Health & Science Univ, Portland, OR, 4Arthritis and Rheumatic diseases, Oregon Health and Science University, Portland, OR, 5Internal Medicine/Rheumatology, Univ of Texas Health Science Center at Houston, Houston, TX, 6Ndorms, Nuffield Orthopaedic Centre, Oxford, United Kingdom, 7Houston, TX, 8School of Social and Community Medicine, Bristol University, Bristol, United Kingdom

    Background/Purpose: Anterior uveitis (AU) is the most common extra-articular manifestation of ankylosing spondylitis (AS), occurring in up to 30-40% of AS cases.  The aim of…
  • Abstract Number: 588 • 2012 ACR/ARHP Annual Meeting

    Discovery of Two Public T Cell Receptor Clonotypes in B27+ Ankylosing Spondylitis by Deep Repertoire Sequence Analysis

    Malek Faham1, Victoria Carlton2 and Robert D. Inman3, 1Research, Sequenta, Inc., South San Francisco, CA, 2Sequenta, Inc., South San Francisco, CA, 3Dept of Medicine/Rheumatology, Toronto Western Research Institute, University Health Network and University of Toronto, Toronto, ON, Canada

    Background/Purpose: The strong association of AS with HLA-B27 implicates a T cell response restricted by this Class I MHC molecule, predicting that specific T Cell…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology